TissueScan, Breast Cancer cDNA Array III

SKU
BCRT303
TissueScan Breast Cancer Tissue qPCR Panel III (5) containing five identical sets of 48 tissues covering four disease stage tissues
New! ER, PR and HER2 in Clinical Info.
  $1,870.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Breast Cancer cDNA Array III
Clinical Info
Diagnosis Category Breast Cancer
Tissue Breast
Shipping Ambient
Description TissueScan Breast Cancer Tissue qPCR Panel III (5) containing five identical sets of 48 tissues covering four disease stage tissues
New! ER, PR and HER2 in Clinical Info.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness
Hesse, Schröder, Brandt et al
JCI Insight (2019) 5 DOI: 10.1172/jci.insight.125543
AI Summary: OriGene’s sclerostin siRNA was used to specifically knock down sclerostin expression in breast cancer cells, enabling the study to assess the role of sclerostin in bone metastases and muscle weakness.
Snippet: MDA-MB-231 cells were transfected with scrambled control siRNA or siRNA against sclerostin (Origene) using Lipofectamine 3000 (Thermo Fisher Scientific) according to the manufacturer’s instructions. For collection of conditioned medium, MDA-MB-231 cells were cultured in the presence of 1% FBS for 24 hours, and conditioned medium was collected and stored at –80°C. Osteoblast differentiation was ind...
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Weng, Tseng, Chen et al
Mol. Cancer (2019) 18 (1), 42 DOI: 10.1186/s12943-019-0988-0
AI Summary: OriGene’s TissueScan Breast Cancer Tissue qPCR Panels (I, III, and IV) were used in this study to quantify MCT-1, IL-6, and IL-6R mRNA levels in breast cancer tissues, enabling analysis of gene expression associated with cancer progression and prognosis.
Snippet: cancer patients. The survival curve was exported using GraphPad Prism software. MCT-1, IL-6 and IL-6R mRNA levels were quantified by using TissueScan Breast Cancer Tissue qPCR Panels (I, III and IV) (OriGene Technologies, Inc., Rockville, MD). Relative mRNA levels were calculated: ΔΔCT = ΔCt cancer-ΔCt normal tissue. The fold change in the gene was calculated using the formula 2−ΔΔCT.;... cancer p...
FigureFigureFigure
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
Leblanc, Sprowl, Alberti et al
J. Clin. Invest. (2018)
AI Summary: OriGene products contributed to this study by providing Tissue Scan Arrays BCRT-303 (cDNA from human breast cancer tissues) and gene-specific primers for OATP1B1 (HP209396) and OATP1B3 (HP213461), which were used for gene expression analysis by real-time PCR.
Snippet: …Gene transcripts were quantified using TaqMan Universal PCR Master Mix (Thermo Fisher Scientific) and primers obtained from Origene that were specific for OATP1B1 (HP209396) and OATP1B3 (HP213461). …
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products